mTOR antagonists (mTA) may be superior to calcineurin inhibitors (CNI) in prevention of cardiac allograft vasculopathy (CAV) after heart transplant (HT). MEDLINE and EMBASE were searched for studies comparing the… Click to show full abstract
mTOR antagonists (mTA) may be superior to calcineurin inhibitors (CNI) in prevention of cardiac allograft vasculopathy (CAV) after heart transplant (HT). MEDLINE and EMBASE were searched for studies comparing the effects of maintenance immunosuppression with mTA + antimetabolites (AM), CNI+mTA or
               
Click one of the above tabs to view related content.